Immunotherapy

Immunotherapy has been an exciting new development in systemic cancer treatment in recent years. From the very beginning, the Netherlands Cancer Institute has been a frontrunner in the field.

By integrating basic, translational, and clinical research, we aim to make a vital contribution to a better understanding of the relationship between the immune system and cancer, to ultimately develop personalized immunotherapy treatment. We are exploring the application of immunotherapy at an earlier stage, developing cellular therapy, mapping out the differences between immune reactions in patients, and working on therapies for cancer types that are currently resistant to immunotherapy.